EGFR and central nervous system cancer: EGFRvIII may also activate NF-kB through mTORC2 [7]: thus, this deletion, that occurs in the majority of GBMs with EGFR amplification [40], may also preserve the function of the EGFR-NF-kB axis in glioma perpetuation.